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The interferon-gamma (IFN-γ) assay is employed as a 
complementary diagnostic test for bovine tuberculosis 
(BTB) in many countries. To simplify this assay, we 
established a 96-well plate format using the ESAT-6 and 
CFP-10 antigens and then employed it to determine the 
extent of Mycobacterium (M.) bovis infection in dairy herds 
with a history of BTB outbreaks in a country where only 
selective culling is practiced. The sensitivity and specificity 
of this IFN-γ assay were 85.9% and 100%, respectively, 
based on comparison with the conventional single 
intradermal tuberculin test (SIDT). The IFN-γ assay was 
also positive in 30.4% and 36.8% of SIDT-negative animals 
from herds with recent and remote BTB outbreaks, 
respectively. Of 14 SIDT-negative, IFN-γ positive cattle, five 
(35.7%) were culture positive and an additional six were 
positive based on a polymerase chain reaction-based test for 
M. bovis. Therefore, the IFN-γ assay has the potential to 
serve as a specific and sensitive test for M. bovis infection in 
dairy cattle. Further, the results indicated that a substantial 
portion of SIDT-negative animals in herds with previous 
BTB outbreaks were actually infected with M. bovis. 
Accordingly, the present selective-culling strategy may 
require modifications to include this more sensitive assay.
Keywords: bovine tuberculosis, IFN-gamma assay, 
Mycobacterium bovis
Introduction
　Bovine tuberculosis (BTB) is one of the major diseases 
caused by Mycobacterium (M.) bovis, a member of the 
Mycobacterium tuberculosis complex. M. bovis can infect 
cattle, deer, wildlife, and humans via respiratory routes [8]. 
BTB has been spreading worldwide and is a major issue 
concerning human public health, particularly in areas where 
unpasteurized milk is consumed. BTB also threatens the 
agricultural economies of many countries [10]. A testing and 
culling strategy has been widely adopted to eradicate BTB 
from dairy cattle herds. The diagnosis of BTB is primarily 
based on the single intradermal test (SIDT), which measures 
M. bovis-specific cell mediated immune (CMI) responses 
following intradermal injection of bovine purified protein 
derivative (PPD) [9]. The use of SIDT and the culling of M. 
bovis-infected animals resulted in a rapid decrease in the 
incidence of BTB. However, as the prevalence of M. bovis 
infection in cattle decreased, the sensitivity and specificity of 
SIDT were reduced due to the rarity of infected animals and 
infection by non-tuberculous mycobacteria (NTM), 
respectively [6]. Therefore, a more sensitive and specific 
diagnostic test is needed. Recently, an interferon-gamma 
(IFN-γ) assay, the Bovigam Bovine Gamma Interferon Test 
(Prionics, Switzerland), was reported to detect M. 
bovis-infected animals with a sensitivity of 82 ~ 100% and a 
specificity of 94∼100% [3,22].
　Although culling of M. bovis-infected animals is 
recommended for effective eradication of BTB, cost 
constraints have resulted in only SIDT-positive animals 
actually being culled in the national BTB control programs 
of many countries, including South Korea. This policy has 
the potential to leave M. bovis-infected but SIDT-negative 
animals in herds that have had BTB outbreaks [3]. 
Repeated SIDT of all animals in herds with BTB outbreaks 
followed by selective culling may eventually be successful 
in eradicating BTB, but its cost will be much higher than a 
culling strategy that is initially effective. It would also be 
more cost effective if a selective culling practice was 
applied based on a highly sensitive assay for the detection 
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of M. bovis infection. 
　With recent development of the IFN-γ assay, it is now of 
great interest to determine the extent of M. bovis infection 
in cattle herds from which all SIDT-positive animals have 
been culled. Bovine IFN-γ assays generally utilize bovine 
PPD and avian PPD antigens to stimulate peripheral 
lymphocytes to eliminate non-specific responders due to 
exposure to NTM [16,20,21]. However, since M. 
tuberculosis complex-specific antigens such as early 
secreted antigenic target protein 6 kDa (ESAT-6) and 
culture filtrate protein 10 kDa (CFP-10) have been widely 
applied for detection of latent tuberculosis infection in 
humans, it would be more applicable for diagnostic 
laboratories to use these antigens instead of bovine and 
avian PPDs. Therefore, this study was conducted to 
establish an IFN-γ assay using the ESAT-6 and CFP-10 
antigens and to determine the extent of M. bovis infection in 
cattle herds in which only SIDT-positive animals have been 
culled. Using this assay, we found that more than 30% of 
SIDT-negative cattle in herds with only partial culling were 
IFN-γ-positive, indicating that the IFN-γ assay may be 
more effective than SIDT at detecting M. bovis infection.
Materials and Methods
Animals
　Animals used in this study were Holstein Friesian cattle 
aged over 1 year from (i) four dairy farms that had had no 
SIDT-positive cattle for more than 5 years based on repeated 
annual testing (n = 100), (ii) four dairy farms that had a 
history of BTB, but did not have any SIDT-positive animals 
within the current testing in a year (remote outbreak) (n = 
114), and (iii) 11 farms that had at least one SIDT-positive 
animal within the current testing in a year (recent outbreak) 
(n = 260). All dairy farms were located in Northern 
Gyoenggi Province, Korea. SIDT-positive cattle were used 
as positive controls (n = 135), while animals from BTB-free 
farms were used as a negative control (n = 100). 
SIDT
　Cattle were injected with 100 μL of bovine PPD (2 
mg/mL) into the caudal fold, and the results of this test 
were based on the skin thickness determined 48∼72 h 
after injection. The animals were considered positive if 
there was an increase of 5 mm or more in skin thickness, 
borderline-positive if the increase in skin thickness was 
more than 3 mm but less than 5 mm, and negative if the skin 
thickened by no more than 3 mm.
Blood collection and IFN-γ assay
　Heparinized blood samples were collected from each 
animal and delivered to the laboratory within 8∼10 h of 
blood collection. Whole blood cultures were performed in 
96-well plates in aliquots of 200 μL/well. Each aliquot was 
stimulated with pokeweed mitogen (PWM; Sigma- 
Aldrich, UK), a mixture of recombinant ESAT-6 and 
CFP-10 antigens, which were expressed in Escherichia coli 
as previously described [4,19], and phosphate buffered 
saline (PBS). PWM and PBS were used as positive and 
negative controls, respectively. The final concentration was 
10 μg/mL for the antigen cocktail (5 μg/mL each of ESAT-6 
and CFP-10) and 5 μg/mL for PWM. Supernatants were 
harvested after incubating the plates at 37oC in a humidified 
5% CO2 incubator for 18∼24 h. IFN-γ was then determined 
by a sandwich enzyme-linked immunosorbent assay 
(ELISA). Briefly, the wells were coated overnight at 4oC 
with 100 μL of 1 μg/mL anti-bovine IFN-γ antibody (AbD 
Serotec, UK) in 50 mM carbonate buffer (pH 9.5). After 
blocking the wells with 10% fetal calf serum (FBS) in PBS 
containing 0.05% Tween (PBS-T) (assay diluent), culture 
supernatants were added to the wells and the samples were 
incubated at 4oC overnight. After washing the plates, 100 
μL of 1 μg/mL biotin-conjugated anti-bovine IFN-γ 
antibody (AbD Serotec) in assay diluent were added and the 
samples were incubated for 60 min. After further washing, 
100 μL of streptavidin-horseradish peroxidase (HRP; AbD 
Serotec) diluted 1 : 10,000 in assay diluent were added and 
incubated for 30 min. After the final wash, 
tetramethylbenzidine (KPL, USA) was added to the wells. 
The reaction was stopped after 25 min by the addition of 50 
μL of 2.5N H2SO4, at which time the absorbance at 450 nm 
was read. Recombinant bovine IFN-γ (AbD Serotec) was 
used to generate a standard curve and IFN-γ levels were 
reported as picograms of protein per milliliter of 
supernatant. Prior to analysis, the mean absorbance value 
from medium control wells was subtracted from that of 
antigen-stimulation wells. Blood culture with antigens and 
the IFN-γ ELISA were both run in duplicate.
M. bovis culture and DNA extraction from hilar 
lymph nodes
　Hilar lymph nodes were homogenized and treated with 
2% NaOH for 15 min, then centrifuged at 3,080 × g for 15 
min. Next, the supernatant was discarded, and tissue 
homogenates were re-suspended in PBS. The 
centrifugation step was then repeated and the supernatant 
was discarded, after which the residues were inoculated 
onto slopes of Ogawa medium containing 0.05% pyruvate 
and incubated for 12 weeks at 37oC. For DNA extraction, 
lymph node homogenates were prepared using a DNeasy 
Blood and Tissue kit (Qiagen, Germany) according to the 
manufacturers’ instructions.
Polymerase chain reaction
　Smart Taq Pre-Mix (Solgent, Korea) was used for 
polymerase chain reaction (PCR) amplification, together 
with DNA prepared as described above and primers 
specific for a 113 bp IS1081 amplicon (5´-CTGCTCTCGA 
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Fig. 1. Standard curve for IFN-γ enzyme-linked immunosorbent
assay showing measurement of recombinant bovine IFN-γ. 
Linearity was determined at IFN-γ concentrations ranging from 
0.078 to 10 ng/mL.
Fig. 2. IFN-γ secretion of mycobacterial antigens in SIDT- 
positive and -negative cattle. ***p < 0.0001.
Fig. 3. ROC curve calculated for IFN-γ assay using the ESAT6 
and CFP10 antigen cocktail. IFN-γ assay AUC = 0.958, 95% 
confidence interval (CI) = 0.930 to 0.985.
CGTTCATCGCCG-3´ and 5´-TGGCGGTAGCCGTTGC 
GC-3´) [18]. The PCR cycle consisted of an initial 
denaturation step of 95oC for 7 min, followed by 35 cycles 
of 30 sec at 94oC, 60 sec at 58oC, and 30 sec at 72oC, and 
then a final extension step of 5 min at 72oC. The PCR 
products were subsequently analyzed by electrophoresis 
with using 1.5% agarose gels (Bioneer, Korea) in 1× 
Tris-acetic acid-EDTA buffer (pH 7.2). A 100-bp DNA 
ladder (Bioneer) was used to estimate the size of the PCR 
products.
Statistical analysis 
　Data were analyzed using GraphPad Prism 5 (GraphPad 
Software, USA). A receiver operating characteristic 
(ROC) curve was generated for the ESAT-6 and CFP-10 
antigen cocktail to select the cutoff values that most 
effectively discriminated positive from negative samples. 
A student’s t test was used to compare the mean IFN-γ 
levels, and the Mann-Whitney U test was used to compare 
nonparametric unpaired data. A p value < 0.05 was 
considered to be significant.
Results
IFN-γ responses in SIDT-positive and SIDT- 
negative cattle   
　A whole blood assay was established in a 96-well culture 
plate format to determine IFN-γ production after 
stimulation with the recombinant ESAT-6 and CFP-10 
antigen cocktail. The IFN-γ concentration in each well was 
determined by comparing the OD values to those of wells 
containing recombinant IFN-γ. Standard curves were 
derived from 8 concentrations ranging from 0.078 ng/mL 
to 10 ng/mL (Fig. 1), and each plate included its own 
standard curve. As the samples were diluted 1 : 2 before the 
assay, the maximum detectable concentration was 20 
ng/mL. The IFN-γ concentrations of SIDT-positive cattle 
were then compared with those of SIDT-negative cattle. 
The majority of the 135 SIDT-positive cattle produced 
more than 0.5 ng/mL of IFN-γ, while none of the 100 
SIDT-negative cattle from BTB-free herds produced this 
level of IFN-γ (Fig. 2). To account for the influence of other 
intrinsic factors that could affect the IFN-γ response, 
interpretation criteria of the results were established based 
on the IFN-γ assay detection limit and the results in 
SIDT-negative control animals and the criteria of the IFN-γ 
assay for diagnosis of M. tuberculosis infection in humans 
(QuantiFERON-TB; Cellestis, Australia). In this study, 
animals that gave an apparently negative result and 
produced less than 0.16 ng/mL IFN-γ in response to the 
PWM mitogen or greater than 5 ng/mL in the PBS control 
were considered indeterminate. These criteria resulted in 
two cattle with indeterminate results because of low IFN-γ 
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Table 1. Results of interferon-gamma (IFN-γ) assay of cattle in herds that had bovine tuberculosis (BTB) outbreaks recently and 
remotely
Cattle herds
IFN-γ assay
Positive number (%) Negative number (%) Indeterminate number (%)
Recent outbreaks  (n = 260)*
Remote outbreaks (n = 114)
79 (30.4)
42 (36.8)
180 (69.2)
72 (63.2)
1 (0.4)
0 (0.0)
*Single intradermal tuberculin test (SIDT)-negative cattle in herds with BTB outbreaks excluding SIDT-positive cattle.
Table 2. Results of SIDT and IFN-γ assay of cattle in herds with 
BTB outbreaks
Herds*
Number of positive/tested (%)
SIDT IFN-γ assay IFN-γ assay excluding SIDT (+)†
A
B
C
D
E
F
G
H
I
J
K
Total
  1/41 (2.4)
  1/27 (3.7)
  1/27 (3.7)
  1/25 (4.0)
  2/46 (4.3)
  1/11 (9.1)
  5/35 (14.3)
  6/37 (16.2)
  8/17 (47.1)
19/35 (54.3)
11/15 (73.3)
56/316 (17.7)
13/41 (31.7)
20/27 (74.1)
  0/27 (0.0)
14/25 (56.0)
  7/46 (15.2)
  4/11 (36.4)
15/35 (42.9)
  7/37 (18.9)
  8/17 (47.1)
23/35 (65.7)
13/15 (86.7)
124/316 (39.2)
12/40 (30.0)
19/26 (73.1)
0/26 (0.0)
13/24 (54.2)
7/44 (15.9)
3/10 (30.0)
10/30 (33.3)
1/31 (3.2)
  1/9 (11.1)
10/16 (62.5)
  3/4 (75.0)
79/260 (30.4)
*Herds with BTB outbreaks. †SIDT-negative cattle in herds with 
BTB outbreaks excluding SIDT-positive cattle.
production, even after stimulation with the PWM mitogen, 
and another that showed IFN-γ production without 
antigenic stimulation. Therefore, these three cattle were 
removed from the subsequent analyses.
Sensitivity and specificity of the IFN-γ assay for 
detection of M. bovis infection
　 A receiver operating characteristics (ROC) curve was 
generated for the IFN-γ assay using the ESAT-6 and 
CFP-10 antigen cocktail to determine the cutoff value for 
an IFN-γ-positive result (Fig. 3). The most appropriate 
cutoff was defined as the point on the ROC curve with the 
greatest distance from the diagonal line (sensitivity = 1 － 
specificity), which resulted in an appropriate cutoff IFN-γ 
concentration of 0.125 ng/mL. However, 0.2 ng/mL of 
IFN-γ was used instead to improve the specificity of the 
IFN-γ assay without losing much sensitivity. When this 
cutoff was applied, 116 (85.9%) of the 135 SIDT-positive 
animals gave IFN-γ assay-positive results, indicating that 
the assay sensitivity was 85.9%. Additionally, none of the 
100 SIDT-negative cattle from the BTB-free herds gave 
IFN-γ-positive results, indicating that its specificity was 
100%. 
Extent of M. bovis infection determined in herds 
with BTB outbreaks using the IFN-γ assay
　 Only SIDT-positive animals were selectively culled 
during annual screening; therefore, we investigated the 
extent of undetected M. bovis infection in the remaining 
cattle using the IFN-γ assay described above. To 
accomplish this, we tested a total of 374 animals from two 
groups of herds that had undergone BTB outbreaks, one 
consisting of 260 SIDT-negative cattle from 11 dairy herds 
that suffered BTB outbreaks as determined by the most 
recent annual test (recent outbreak), and another composed 
of 114 SIDT-negative cattle from four herds with a history 
of BTB outbreaks, but in which all of the animals tested 
negative in the most recent annual test (remote outbreak). 
The mean IFN-γ concentration of the animals from the 
herds with remote BTB outbreaks was significantly higher 
than that of animals from the herds with recent BTB 
outbreak  (data not shown). When the cutoff criteria set by 
this study were applied for the IFN-γ assay, 79 (30.4%) of 
the 260 SIDT-negative cattle from herds with recent BTB 
outbreaks and 42 (36.8%) of 114 SIDT-negative animals 
from herds with BTB outbreaks that occurred at least 2 
months previously tested positive for IFN-γ, respectively 
(Table 1). These results indicate that a substantial portion 
of animals had an infection that was not detected by the 
annual SIDT screen. In addition, although there was no 
significant difference between groups, there appeared to be 
a trend towards a greater number of M. bovis infections 
over time. However, there was marked variation in M. 
bovis infection rates among dairy cattle herds, regardless 
of the number of SIDT-positive animals (Table 2). In herd 
B with a recent BTB outbreak, only one (3.7%) of 27 cattle 
was SIDT-positive, while 20 (74.1%) were IFN-γ-positive; 
thus, 19 animals with M. bovis infection were not detected 
by SIDT. Conversely, six (16.2%) of 37cattle in herd H 
with a recent BTB outbreak  were SIDT-positive, while 
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Fig. 4. PCR analysis and visible lesions on hilar lymph nodes of SIDT-negative cattle. (A) Electrophoresis on 1.5% agarose gel showing
the 113 bp PCR products after amplification with the IS1081 F/R primers. Lane M, 100 bp DNA size marker; Lane 1, M. bovis DNA;
Lanes 2∼7, samples of hilar lymph nodes. (B) Visible lesions of hilar lymph nodes from cattle showing positive response to IFN-γ
assay, but negative response to SIDT.
Table 3. Results of post-mortem examination of IFN-γ assay- 
positive, but SIDT-negative cattle
Cattle Visible lesion Culture PCR (IS1081)
  1
  2
  3
  4
  5
  6
  7
  8
  9
10
11
12
13
14
Total*
+
−
+
−
−
+
+
+
−
+
−
−
−
−
6/14
+
−
+
+
−
+
+
−
−
−
−
−
−
−
5/14
+
+
+
+
−
+
+
+
+
+
+
−
−
+
11/14
*The number of positive/the number of tested. PCR: polymerase 
chain reaction.
seven (18.9%) of 37 cattle were IFN-γ-positive; thus, only 
one additional animal was identified by the developed 
assay. Based on the results above, total depopulation of 
animals in herds that have had a BTB outbreak is more 
suitable as a control practice.
Post-mortem examination for confirmation of M. 
bovis infection 
　To confirm M. bovis infection among SIDT-negative, but 
IFN-γ-positive cattle, we slaughtered 14 animals and 
examined them for the presence of visible lesions. 
Additionally, we removed the hilar lymph nodes for 
culture tests and molecular detection of M. bovis (Fig. 4). 
No visible lesions were found in the internal organs 
(including the lung, spleen, liver, and kidney), but six cattle 
had granuloma lesions in their hilar lymph nodes. 
Additionally, M. bovis was isolated from the hilar lymph 
nodes of five cattle, four of which had a caseous lesion. 
Eleven cattle, including six with caseous lesions, were M. 
bovis-specific IS1081 PCR positive, confirming that the 
IFN-γ assay used in this study could detect M. bovis in a 
portion of dairy cattle that were SIDT negative (Table 3).  
Discussion
　This study demonstrated that an IFN-γ assay using the 
ESAT-6 and CFP-10 antigen cocktail is useful for detecting 
M. bovis infection among dairy cattle with a sensitivity of 
86% and a specificity of 100% when compared to SIDT. 
Although this study was limited in that it used the SIDT 
results as the criteria for M. bovis infection instead of 
culture results, the IFN-γ assay results obtained in this 
study were comparable to those obtained in other studies. 
For example, a study of 1,479 cattle from herds with BTB 
outbreaks in Spain revealed that the IFN-γ assay was 
positive in 149 (85.6%) of 174 SIDT-positive cattle and 
negative in 1,194 (91.5%) of 1,305 SIDT-negative cattle 
[5]. In another study of 220 cattle at high risk of BTB in 
Brazil, all of the 106 SIDT-positive cattle were also 
positive for IFN-γ, representing a sensitivity of 100%, and 
there were 20 additional cattle that were SIDT-negative, 
but IFN-γ assay-positive. Of these 20 animals, 14 were 
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either culture positive or became SIDT-positive upon 
follow up tests [7]. Therefore, the results obtained by the 
IFN-γ assay in this study were comparable to those 
employed in other studies.
　In this study, we used the M. tuberculosis complex-specific 
antigens, ESAT-6 and CFP-10, to reduce false-positive 
results. During early development of the IFN-γ assay, the 
PPD-B and PPD-A antigens were used to increase 
specificity, but they resembled those of the comparative 
cervical tuberculin test [16,20,21]. However, owing to the 
availability of M. tuberculosis complex-specific antigens, 
there have been efforts to develop an IFN-γ assay with 
higher sensitivity and specificity using the ESAT-6, 
CFP-10, and other RD1 antigens [11,13]. For example, the 
ESAT-6 antigen alone gave a comparable result to PPD-B 
in an in vitro IFN-γ assay of 19 animals infected 
experimentally with M. bovis [14]. In an extensive 
analysis of various M. tuberculosis complex-specific 
antigens, ESAT-6/CFP-10 had the greatest sensitivity 
(85%), and a specificity of 97% [1]. Use of the ESAT-6 
antigen in the IFN-γ assay also gave a higher specificity 
than that achieved using the PPD-D/PPD-A-based IFN-γ 
assay (100% vs. 94%, respectively) [2]. Therefore, the 
IFN-γ assay established in this study produces results 
comparable to those employed in other studies.
　Possibly the most important finding in this study is that 
more than 30% of SIDT-negative cattle were positive 
based on IFN-γ assay of herds that had suffered recent BTB 
outbreaks. These findings suggest that selective culling of 
SIDT-positive animals under these circumstances is 
inadequate because it leaves a substantial portion of 
animals with M. bovis infection, which may act as sources 
of infection to other animals in the herds. The greater 
proportion of cattle testing positive presumably reflects the 
higher sensitivity of the IFN-γ assay than the SIDT. This 
greater sensitivity of the IFN-γ assay for detection of M. 
bovis infection is concordant with the findings of a number 
of previous studies. For example, in a study of 1,362 cattle 
from M. bovis-infected herds, the IFN-γ assay had a 
sensitivity of 82% and specificity of 99%, both of which 
were higher than those of SIDT, for which the sensitivity 
and specificity were 68% and 97%, respectively [20]. This 
greater sensitivity of the IFN-γ assay may reflect the fact 
that the IFN-γ response occurs at an early stage of M. bovis 
infection, while the changes that define a positive SIDT 
result only become apparent later. This assumption is 
supported by an experimental infection of cattle with M. 
bovis in which an increase in IFN-γ was detected as early as 
2 weeks after infection in some animals, and all cattle were 
positive 4 weeks after infection [15]. However, under 
natural conditions, the infection dose may vary 
considerably, along with the time required for a positive 
IFN-γ assay or SIDT result. In a field study, IFN-γ detected 
changes 90∼150 days earlier than the SIDT [7]. This may 
help explain our finding that IFN-γ positivity was slightly 
higher among the SIDT-negative cattle from herds with 
earlier BTB outbreaks (36.8%) than herds in which the 
outbreaks were more recent (30.4%). Thus, the IFN-γ 
assay may be more effective at detecting M. bovis 
infections than SIDT in herds with BTB outbreaks. 
　In an attempt to demonstrate that there was a definite M. 
bovis infection among SIDT-negative, but IFN-γ positive 
cattle, we found that 11 (78.6%) of 14 cattle with these test 
results showed evidence of M. bovis infection either by 
culture tests (5 animals; 35.7%) or the presence of M. bovis 
DNA as determined using a PCR-based assay. Although 
the numbers were small, these findings still clearly 
demonstrate that the IFN-γ assay can detect genuine M. 
bovis infections in the majority of SIDT-negative animals. 
This finding is also supported by those of previous studies. 
In one such study, 23 (43.4%) of 53 cattle that were 
IFN-γ-positive but SIDT-negative were found to be culture 
positive for M. bovis [20], while in other studies, 34%∼ 
38% of IFN-γ-positive but SIDT-negative animals were 
positive for M. bovis culture [12,17]. Therefore, the IFN-γ 
assay using the ESAT-6 and CFT-10 antigen cocktail 
employed in this study is considered to be specific for 
detection of M. bovis infection, even in SIDT-negative 
cattle.
　Taken together, our findings suggest that the IFN-γ assay 
described in this study is an effective test for M. bovis 
infection in cattle. Furthermore, if the results of this assay 
had been applied in addition to the standard SIDT in annual 
testing, many more cattle should have been culled. 
Accordingly, these findings indicate the need for an 
additional sensitive test(s) for M. bovis infection to enable 
more effective control of BTB, and that the IFN-γ assay 
could serve as such a test, particularly in countries where 
only a selective culling strategy based on SIDT results is in 
use. The only other practical method of controlling this 
disease may be the total culling of infected herds, although 
this would have significant economic consequences.
Acknowledgments
　This work was supported in part by a grant from the 
Korean Health 21 R&D Project, the Ministry of Health and 
Welfare, Korea (A010381), and a grant from the Brain 
Korea 21 Project for Medical Sciences at Yonsei 
University College of Medicine.
Conflict of interest
  There is no conflict of interest.
References
1. Aagaard C, Govaerts M, Meikle V, Vallecillo A, 
IFN-gamma assay for Mycobacterium bovis infection    265
Gutierrez-Pabello JA, Suarez-Güemes F, McNair J, 
Cataldi A, Espitia C, Andersen P, Pollock JM. Optimizing 
antigen cocktails for detection of Mycobacterium bovis in 
herds with different prevalences of bovine tuberculosis: 
ESAT6-CFP10 mixture shows optimal sensitivity and 
specificity. J Clin Microbiol 2006, 44, 4326-4335.
2. Buddle BM, Ryan TJ, Pollock JM, Andersen P, de Lisle 
GW. Use of ESAT-6 in the interferon-γ test for diagnosis of 
bovine tuberculosis following skin testing. Vet Microbiol 
2001, 80, 37-46.
3. de la Rua-Domenech R, Goodchild AT, Vordermeier 
HM, Hewinson RG, Christiansen KH, Clifton-Hadley 
RS. Ante mortem diagnosis of tuberculosis in cattle: a 
review of the tuberculin tests, γ-interferon assay and other 
ancillary diagnostic techniques. Res Vet Sci 2006, 81, 
190-210.
4. Dillon DC, Alderson MR, Day CH, Bement T, 
Campos-Neto A, Skeiky YA, Vedvick T, Badaro R, Reed 
SG, Houghton R. Molecular and immunological 
characterization of Mycobacterium tuberculosis CFP-10, an 
immunodiagnostic antigen missing in Mycobacterium bovis 
BCG. J Clin Microbiol 2000, 38, 3285-3290.
5. González Llamazares OR, Gutiérrez Martín CB, 
Alvarez Nistal D, de la Puente Redondo VA, Dominguez 
Rodríguez L, Rodríquez Ferri E. Field evaluation of the 
single intradermal cervical tuberculin test and the 
interferon-γ assay for detection and eradication of bovine 
tuberculosis in Spain. Vet Microbiol 1999, 70, 55-66.
6. Hope JC, Thom ML, Villarreal-Ramos B, Vordermeier 
HM, Hewinson RG, Howard CJ. Exposure to 
Mycobacterium avium induces low-level protection from 
Mycobacterium bovis infection but compromises diagnosis 
of disease in cattle. Clin Exp Immunol 2005, 141, 432-439.
7. Lilenbaum W, Schettini JC, Souza GN, Ribeiro ER, 
Moreira EC, Fonseca LS. Comparison between a γ-IFN 
assay and intradermal tuberculin test for the diagnosis of 
bovine tuberculosis in field trials in Brazil. Zentralbl 
Veterinarmed B. 1999, 46, 353-358.
8. Mathews F, Macdonald DW, Taylor GM, Gelling M, 
Norman RA, Honess PE, Foster R, Gower CM, Varley S, 
Harris A, Palmer S, Hewinson G, Webster JP. Bovine 
tuberculosis (Mycobacterium bovis) in British farmland 
wildlife: the importance to agriculture. Proc Biol Sci 2006, 
273, 357-365.
9. Monaghan ML, Doherty ML, Collins JD, Kazda JF, 
Quinn PJ. The tuberculin test. Vet Microbiol 1994, 40, 
111-124.
10. Morris RS, Pfeiffer DU, Jackson R. The epidemiology of 
Mycobacterium bovis infections. Vet Microbiol 1994, 40, 
153-177.
11. Mustafa AS, Cockle PJ, Shaban F, Hewinson RG, 
Vordermeier HM. Immunogenicity of Mycobacterium 
tuberculosis RD1 region gene products in infected cattle. 
Clin Exp Immunol 2002, 130, 37-42.
12. Neill SD, Cassidy J, Hanna J, Mackie DP, Pollock JM, 
Clements A, Walton E, Bryson DG. Detection of 
Mycobacterium bovis infection in skin test-negative cattle 
with an assay for bovine interferon-gamma. Vet Rec 1994, 
135, 134-135.
13. Pollock JM, Girvin RM, Lightbody KA, Clements RA, 
Neill SD, Buddle BM, Andersen P. Assessment of defined 
antigens for the diagnosis of bovine tuberculosis in skin 
test-reactor cattle. Vet Rec 2000, 146, 659-665.
14. Pollock JM, Andersen P. Predominant recognition of the 
ESAT-6 protein in the first phase of interferon with 
Mycobacterium bovis in cattle. Infect Immun 1997, 65, 
2587-2592.
15. Rhodes SG, Palmer N, Graham SP, Bianco AE, 
Hewinson RG, Vordermeier HM. Distinct response 
kinetics of gamma interferon and interleukin-4 in bovine 
tuberculosis. Infect Immun 2000, 68, 5393-5400.
16. Rothel JS, Jones SL, Corner LA, Cox JC, Wood PR. The 
gamma-interferon assay for diagnosis of bovine tuberculosis 
in cattle: conditions affecting the production of 
gamma-interferon in whole blood culture. Aust Vet J 1992, 
69, 1-4.
17. Scacchia M, Lelli R, Petrini A, Prencipe V, Calistri P, 
Giovannini A. Use of innovative methods in the eradication 
of bovine tuberculosis. J Vet Med B Infect Dis Vet Public 
Health 2000, 47, 321-327.
18. Taylor GM, Worth DR, Palmer S, Jahans K, Hewinson 
RG. Rapid detection of Mycobacterium bovis DNA in cattle 
lymph nodes with visible lesions using PCR. BMC Vet Res 
2007, 3, 12.
19. Wang BL, Xu Y, Wu CQ, Xu YM, Wang HH. Cloning, 
expression, and refolding of a secretory protein ESAT-6 of 
Mycobacterium tuberculosis. Protein Expr Purif 2005, 39, 
184-188.
20. Wood PR, Corner LA, Rothel JS, Baldock C, Jones SL, 
Cousins DB, McCormick BS, Francis BR, Creeper J, 
Tweddle NE. Field comparison of the interferon-gamma 
assay and the intradermal tuberculin test for the diagnosis of 
bovine tuberculosis. Aust Vet J 1991, 68, 286-290.
21. Wood PR, Corner LA, Rothel JS, Ripper JL, Fifis T, 
McCormick BS, Francis B, Melville L, Small K, de Witte 
K, Tolson J, Ryan TJ, de Lisle GW, Cox JC, Jones SL. A 
field evaluation of serological and cellular diagnostic tests 
for bovine tuberculosis. Vet Microbiol 1992, 31, 71-79.
22. Wood PR, Jones SL. BOVIGAMTM: an in vitro cellular 
diagnostic test for bovine tuberculosis. Tuberculosis (Edinb) 
2001, 81, 147-155.
